Publication Name	World Journal of Clinical Cases
Manuscript ID	84511
Country	India

Received	2023-03-17 02:30
Peer-Review Started	2023-03-17 02:34
To Make the First Decision
Return for Revision	2023-05-12 01:07
Revised	2023-05-12 14:22
Second Decision	2023-05-17 02:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-05-17 07:48
Articles in Press	2023-05-17 07:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-05-26 07:54
Publish the Manuscript Online	2023-06-12 08:16

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
Manuscript Source	Invited Manuscript
All Author List	Narmadha Rathinasamy, Sathish Muthu and Anand Krishnan
ORCID	Author(s) ORCID Number Narmadha Rathinasamy http://orcid.org/0000-0001-8176-5854 Sathish Muthu http://orcid.org/0000-0002-7143-4354 Anand Krishnan http://orcid.org/0000-0002-8886-8482
Funding Agency and Grant Number
Corresponding Author	Sathish Muthu, Visiting Professor, MS, N/A, N/A, Department of Orthopaedics, Orthopaedic Research Group, Ramanathapuram, Coimbatore 641045, Tamil Nadu, India. drsathishmuthu@gmail.com
Key Words	Immunotherapy; Neo-adjuvant chemotherapy; Oral cancer
Core Tip	There is a need to potentiate the effect of neo-adjuvant chemotherapy (NACT) in oral cancers. The utilization of immunotherapy to enhance NACT has been shown to reduce metastasis and recurrence. Hence, the concept of low-dose immunotherapy as a potentiator of NACT could be implemented in routine practice. Moreover, low-dose immunotherapy-enhanced NACT helps us understand the predictors of treatment response.
Publish Date	2023-06-12 08:16
Citation	Rathinasamy N, Muthu S, Krishnan A. Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers. World J Clin Cases 2023; 11(17): 3976-3979
URL	https://www.wjgnet.com/2307-8960/full/v11/i17/3976.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i17.3976

Full Article (PDF)	WJCC-11-3976-with-cover.pdf
Full Article (Word)	WJCC-11-3976.docx
Manuscript File	84511_Auto_Edited-JLW.docx
Answering Reviewers	84511-Answering reviewers.pdf
Audio Core Tip	84511-Audio core tip.ogg
Conflict-of-Interest Disclosure Form	84511-Conflict-of-interest statement.pdf
Copyright License Agreement	84511-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	84511-Language certificate.pdf
Peer-review Report	84511-Peer-review(s).pdf
Scientific Misconduct Check	84511-Bing-Fan JR-2.png
Scientific Editor Work List	84511-Scientific editor work list.pdf
CrossCheck Report	84511-CrossCheck report.pdf
CrossCheck Report	84511-CrossCheck.png